Fertility Awareness Effectiveness

Use of ovulation predictor kits as adjuncts when using fertility awareness methods (FAMs): a pilot study

Leiva R, Burhan U, Kyrillos E, Fehring R, McLaren R, Dalzell C, Tanguay E

Published May 2014 Journal of the American Board of Family Medicine : JABFM, 27(3), 427-429
DOI 10.3122/jabfm.2014.03.130255 PMID 24808123

RRM Academy Synopsis

LH kits used with FAMs identified the luteal phase in 23 of 23 cycles

Urinary luteinizing hormone (LH) kits identified the luteal phase in 23 of 23 cycles, compared with 20 of 23 for fertility awareness methods (FAMs) alone, in a 2014 crossover pilot of 23 Canadian women. The women said they had trouble identifying the infertile phase after ovulation. Blood progesterone confirmed the luteal phase.

Key Findings

  • Each of the 23 women supplied information on 2 cycles, for a total of 46 cycles, one with an LH kit alongside a FAM and one with a FAM only.
  • LH kits identified the luteal phase in 23 of 23 cycles (proportion 1.00), and FAM only in 20 of 23 cycles (proportion 0.87), a statistically significant difference.
  • The relative risk of FAM/LH was 0.87 (95% CI 0.72 to 0.97), and the absolute difference (LH minus FAM) was 0.13 (0.03 to 0.28).
  • Among identified cycles, the mean length of infertility was 10.3 days with LH kits and 10 days with FAM only, which was not statistically significant.
  • Participants used a mean of 15 kits per cycle.

Interpretation

The study used a block-allocation crossover design. Each of 23 women contributed one cycle with an LH kit alongside her FAM and one cycle with her FAM only. Enrollment order set the sequence, and serum progesterone confirmed the luteal phase. The women perceived difficulty identifying the infertile phase after ovulation. Of the 23 women, 14 used a mucus-based method and 9 used mucus temperature. The authors note that LH kits may not confirm the luteal phase in some other settings, such as breastfeeding and premenopause.

RRM Context

Restorative Reproductive Medicine uses charting to read the ovulatory cycle. The Marquette Method adds urine hormone monitoring to charted signs. This study pairs a low-cost LH kit with charting.

Abstract

Purpose

Difficult clinical signs such as confusing cervical mucus or erratic basal body temperature can make the use of fertility awareness methods (FAMs) difficult in some cases. The goal of this study was to assess the feasibility of using a cheap urinary luteinizing hormone (LH)-surge identification kit as an adjunct to identify the infertile phase after ovulation when facing these scenarios.

Methods

The study used a block-allocation, crossover, 2-arm methodology (LH kit/FAM vs FAM only). Comparison of the 2 arms was done with regard to the accuracy of identification (yes/no) of the luteal phase in each cycle as confirmed by serum progesterone concentrations.

Results

We recruited 23 Canadian women currently using FAM, aged 18 to 48 years, who have had menstrual cycles 25 to 35 days long for the past 3 months and perceive themselves to have difficulty with identifying the infertile phase after ovulation. LH kits identified 100% of the luteal phases, whereas FAM indentified 87% (statistically significant). In those identified cycles, LH kits provided a mean of 10.3 days of infertility, and FAM only provided 10 days of infertility (not statistically significant).

Conclusions

Among this population, LH kits may offer an adjunct for women who may wish to have an additional double-check. However, there are still clinical circumstances when even an LH kit does not provide confirmation. More research in this area is encouraged.

Read the guide

  • Fertility Awareness Methods Compared

    Clinician-reviewed comparison of fertility awareness-based methods (Billings, Creighton, Sensiplan, Marquette, Standard Days, apps). Every effectiveness figure cited and labeled by metric.

    30 min read

Topics

By this author

Related research

Fertility Awareness › Effectiveness › Comparative Effectiveness · Menstrual Cycle › Cycle Biomarkers › Hormonal Markers · Reproductive Endocrinology › Luteal Phase › Luteal Phase Deficiency
Rene Leiva, Ula Burhan, Edmond Kyrillos, Richard Fehring, Robin McLaren, Catherine Dalzell, Elizabeth Tanguay
R Leiva, U Burhan, E Kyrillos, Rick Fehring, Dick Fehring, Rich Fehring, R Fehring, R McLaren, Cathy Dalzell, Kate Dalzell, C Dalzell, Liz Tanguay, Beth Tanguay, Betsy Tanguay, E Tanguay
PMID 24808123 24808123 DOI 10.3122/jabfm.2014.03.130255 10.3122/jabfm.2014.03.130255 Leiva et al. 2014, Leiva 2014